112 results on '"Soudet S"'
Search Results
2. Négativation des anticorps anti-phospholipdes au cours du syndrome des anti-phospholipdes
3. Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study.
4. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19
5. Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study
6. Epidemiology and risk factors for cancer-associated thrombosis
7. Maladie thromboembolique veineuse associée au cancer : combien de patients atteints de cancer du poumon vus en pratique clinique seraient éligibles à un essai contrôlé randomisé sur les AODs ?
8. Cancer Associated Thrombosis:how many lung cancer patients seen in clinical practice would be eligible to a DOAC randomized controlled trial?
9. PO-50: Molecular landscape of the coagulome of oral squamous cell carcinoma
10. PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?
11. Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?
12. Prévalence des anticorps dirigés contre l’annexine A2 chez des patients COVID-19 en réanimation
13. Perspectives d’utilisation de la filière de soins de la maladie thromboembolique veineuse du CHU d’Amiens par les médecins généralistes de la Somme
14. Une thrombose veineuse profonde révélant un syndrome d’hyper-IgG4
15. Quel schéma thérapeutique de la MTEV au cours de la COVID-19 ?
16. Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?
17. Perspectives d’utilisation de la filière de soins de la maladie thrombo-embolique veineuse du CHU d’Amiens par les médecins généralistes de la Somme
18. Une thrombose veineuse profonde révélant un syndrome d’hyper-IgG4
19. Mélancolie catatonique et maladie thromboembolique veineuse : une association à risque
20. Thromboangéite oblitérante (maladie de Buerger) et grossesses
21. Maladie de Buerger : caractéristiques et suivi à long terme d’une série de 224 patients
22. Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?
23. THU0435 Long-term outcome and prognosis factors of complications in thromboangiitis obliterans (BUERGER’S DISEASE): a multicenter study of 224 patients
24. Maladie de Buerger (thromboangéite oblitérante) : aspect clinique et pronostiques à long terme de 224 patients
25. Long term use of metformin in idiopathic cyclic edema, report of thirteen cases and review of the literature
26. Maladie de Buerger : caractéristiques et suivi à long terme d’une série de 174 patients
27. Endocardite à Bacillus cereus avec probable porte d’entrée cutanée
28. Un syndrome de Schnitzler révélé par une maladie de Castleman : cas clinique et description histologique
29. Le spectre clinique de la maladie de Buerger a-t-il évolué au cours des quarante dernières années ?
30. Thromboangéite oblitérante (maladie de Buerger) : caractéristiques et suivi à long terme d’une série de 174 patients
31. Diffuse calcinosis cutis in systemic lupus erythematosus: an exceptional complication
32. Endocardite à Bacillus cereus : une cause rare d’endocardite, une porte d’entrée inhabituelle
33. Utilisation prolongée de la metformine dans le traitement de l’œdème cyclique idiopathique : à propos de 13 cas et revue de la littérature
34. TEMPORARY REMOVAL: PO-50: Molecular landscape of the coagulome of oral squamous cell carcinoma.
35. Endocardite à Bacillus cereusavec probable porte d’entrée cutanée
36. TEMPORARY REMOVAL: PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?
37. Intravascular Lipoma: Not a Legend.
38. Retrospective Cohort Study on EVAR Open Surgical Conversion: Focus on Endoleaks With Wrong Preoperative Categorization.
39. Letter: Anticoagulants in Venous Thrombosis, a Pivotal Risk Factor: Authors' Reply.
40. Venous Thrombosis Recurrence After Catheter-Related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Retrospective Analysis.
41. Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?
42. An MRI Radiomics Approach to Predict the Hypercoagulable Status of Gliomas.
43. Contemporary Minimally Invasive Surgery for TASC-D Aorto-Iliac Lesions: Analysis of Outcomes and Risk Factors for Primary and Secondary Patency.
44. Annexin-V positive extracellular vesicles level is increased in severe COVID-19 disease.
45. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
46. The coagulome of oral squamous cell carcinoma: examining the role and regulation of coagulation in oral cancers using a systems approach.
47. Myocardial infarction in women under 50: Possible implication of clonal haematopoiesis of indetermined potential.
48. Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD).
49. Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?
50. Under-Prescription of Medical Treatment for Peripheral Artery Disease in the Under 50s: A Retrospective Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.